All Stories
- Financial burden of productivity loss in severe asthma and impact of biologic therapy
Article

- Biologic Prescription Patterns and Biomarker Determinants of First‐Line Dupilumab in Danish Adult Patients With Severe Asthma and Comorbid Atopic Dermatitis
Article

- Impact of natal and childhood metabolic markers on childhood asthma burden – a nationwide cohort study
Article

- Prevalence, Change and Burden of Systemic Corticosteroid Use in Type 2 Inflammation Associated Diseases Over 25 Years – A Nationwide Danish Study
Article

- Fertility outcomes in women with asthma: a Danish nationwide cohort study
Article

- The impact of biologic therapy on work capacity and workforce attachment in patients with severe asthma
Article

- Pre-biologic disease trajectories are associated with morbidity burden and biologic treatment response in severe asthma
Article

- Early Reduction of FeNO on Anti‐IL5 Biologics Is Associated With Clinical Remission of Severe Asthma
Article

- Real-world phenotyping and risk assessment of childhood asthma burden using national registries
Article

- Clinical Response and Remission in Patients With Severe Asthma Treated With Biologic Therapies
Article

- Impact of family socioeconomic position on childhood asthma outcomes, severity, and specialist referral – a Danish nationwide study
Article

- Tobacco Exposure and Efficacy of Biologic Therapy in Patients With Severe Asthma: A Nationwide Study From the Danish Severe Asthma Register
Article

- Childhood Asthma and Parental Antidepressant Use in a Nationwide Danish Cohort
Article

- Burden and unmet need for specialist care in poorly controlled and severe childhood asthma in a Danish nationwide cohort
Article

- Beyond direct costs: individual and societal financial burden of asthma in young adults in a Danish nationwide study
Article

- Adherence to inhaled corticosteroids in relation to quality of life and symptoms of anxiety and depression in asthma
Article

- Complete response to anti-IL5 biologics for severe asthma in a real-life setting
Article

- Disease Control, Not Severity, Drives Job Absenteeism in Young Adults with Asthma – A Nationwide Cohort Study
Article

- Determining Persistence with an Inhaled Corticosteroid in Asthma: Assessment Using an Objective Measurement vs the Self-Reported Foster Score
Article

- High Use of Antidepressant Medication in Both Mild-to-Modelate and Possible Severe Asthma – A Nationwide Cohort Study
Article

- Socioeconomic status is associated with healthcare seeking behaviour and disease burden in young adults with asthma – A nationwide cohort study
Article

- Do clinical traits differ between GINA 2020 Steps 4 and 5 in primary versus secondary care?
Article

- Socioeconomic predictors of specialist referral for possible severe asthma in a public healthcare setting
Article

- Adherence with controller medication in adults with asthma – impact of hospital admission for acute exacerbation
Article

- Beta-Blockers in High-Risk Outpatients with Chronic Obstructive Pulmonary Disease are Associated with All-Cause Mortality – The STATUETTE Cohort Study
Article

- Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality – The STATUETTE Cohort Study [Corrigendum]
Article

- Hydroxychloroquine as a primary prophylactic agent against SARS-CoV-2 infection: A cohort study
Article

- Inhaled Corticosteroid Therapy in Bronchiectasis is Associated with All-Cause Mortality: A Prospective Cohort Study
Article

- Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19: a randomised double-blinded placebo-controlled trial
Article

- Self-reported vs. objectively assessed adherence to inhaled corticosteroids in asthma
Article

- Socioeconomic biases in asthma control and specialist referral of possible severe asthma
Article

- Remission and Changes in Severity Over 30 Years in an Adult Asthma Cohort
Article

- Statins in High-Risk Chronic Obstructive Pulmonary Disease Outpatients: No Impact on Time to First Exacerbation and All-Cause Mortality – The STATUETTE Cohort Study
Article

- A causal relationship between rheumatoid arthritis and bronchiectasis? A systematic review and meta-analysis
Article

- Late Breaking Abstract - Burden of disease, diagnostic work-up and management of bronchiectasis in outpatient clinics – a five-year prospective cohort study
Article

- Late Breaking Abstract - Inhaled corticosteroids in bronchiectasis is associated to increased morbidity, Pseudomonas colonization and mortality – a five-year prospective cohort study
Article

- Late Breaking Abstract - Nationwide asthma management and disease control in primary versus secondary care – a real-world evidence study
Article

- Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial
Article

- <p>High suPAR and Low Blood Eosinophil Count are Risk Factors for Hospital Readmission and Mortality in Patients with COPD</p>
Article

- The biomarkers suPAR and blood eosinophils are associated with hospital readmissions and mortality in asthma – a retrospective cohort study
Article

- Soluble urokinase plasminogen activator receptor (suPAR) is associated with COPD readmission and mortality
Article

- Soluble urokinase plasminogen activator receptor (suPAR) predicts hospital readmissions and all-cause mortality in patients admitted with asthma
Article

- Genetic associations and regulation of expression indicate an independent role for 14q32 snoRNAs in Human Cardiovascular Disease
Article
- Circulating Small Non-coding RNAs as Biomarkers for Recovery After Exhaustive or Repetitive Exercise
Article
